다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Zevra Therapeutics Inc (ZVRA)
Zevra Therapeutics Inc (ZVRA) 뉴스

ZVRA

Zevra Therapeutics (ZVRA)

Zevra Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ZVRA

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/17	21:30	GlobeNewswire Inc.	Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/12/07	07:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/12/07	07:00	GlobeNewswire Inc.	Zevra Therapeutics Announces Organizational Changes	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/26	21:30	GlobeNewswire Inc.	Zevra Therapeutics to Participate at Upcoming Investor Conferences	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/22	06:51	GlobeNewswire Inc.	Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/15	06:53	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/15	03:00	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/14	06:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/13	06:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/13	06:05	GlobeNewswire Inc.	Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/12	06:36	GlobeNewswire Inc.	Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/11/06	21:30	GlobeNewswire Inc.	Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/31	20:30	GlobeNewswire Inc.	Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/17	05:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/10	20:30	GlobeNewswire Inc.	Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/10/09	22:00	GlobeNewswire Inc.	NUCDF and Zevra Therapeutics Launch Check Ammonia Campaign to Highlight Critical Importance of Prompt, Accurate Blood Ammonia Testing for Diagnosing Urea Cycle Disorders	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/24	20:30	GlobeNewswire Inc.	Zevra Therapeutics to Present Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at Sleep Europe 2024	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/21	05:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/21	01:08	GlobeNewswire Inc.	Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/09/06	21:30	GlobeNewswire Inc.	Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/29	20:30	GlobeNewswire Inc.	Zevra Therapeutics to Participate at Upcoming Investor Conferences	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/14	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/14	05:05	GlobeNewswire Inc.	Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/13	18:45	IH Market News	U.S. Futures Climb Before Inflation Data; Oil Slips on OPEC Demand Cut	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/10	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/10	05:54	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	13:00	GlobeNewswire Inc.	Zevra Therapeutics Announces Pricing of Underwritten Offering of Common Stock	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	05:06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ZVRA	Zevra Therapeutics Inc
2024/08/09	05:01	GlobeNewswire Inc.	Zevra Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:ZVRA	Zevra Therapeutics Inc

검색 관련기사 보기:NASDAQ:ZVRA

1 2 3 4 5 다음 >>

Health Care Select Sector

Gold vs US Dollar

US Dollar vs Yen

Financial Select Sector

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관